Market Place
Sourcing Support
Talphera reduces NEPHRO CRRT study size to 70 patients
31 Mar 2025 //
PR NEWSWIRE
Talphera Announces 2024 Financial Results and Corporate Update
31 Mar 2025 //
PR NEWSWIRE
Talphera to Host Q4 2024 Financial Results Call on March 31, 2025
26 Mar 2025 //
PR NEWSWIRE
Talphera, FDA Agree to Adjust NEPHRO CRRT Study Patient Numbers
14 Jan 2025 //
PR NEWSWIRE
Talphera to Host Q3 2024 Results Call & Corporate Update
06 Nov 2024 //
PR NEWSWIRE
Talphera To Participate In Fireside Chat At 2024 Maxim Summit
08 Oct 2024 //
PR NEWSWIRE
Talphera Enrolls First Patient In Nafamostat Anticoagulation Trial
19 Aug 2024 //
PR NEWSWIRE
Talphera to Participate at A.G.P. Virtual Healthcare Conference
16 May 2024 //
PR NEWSWIRE
Talphera Announces Fourth Quarter 2023 Financial Results
06 Mar 2024 //
PR NEWSWIRE
Talphera Announces Reduction in Size of its Board of Directors
01 Mar 2024 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.